ESTRO37_ProgrammeBook

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

POSTERS

> Borderline pancreatic adenocarcinomas: is there a place for a neoadjuvant treatment?

M. Terlizzi (France), C. Pouypoudat, E. Buscail, S. Adgié, N. Leduc, E. Terrebonne, D. Smith, J.F. Blanc, C. Cassinotto, C. Laurent, L. Chiche, G. Belleannée, R. Trouette, V. Vendrely > Inflammatory markers in patients receiving R0 resection and chemoradiation for gastric cancer M.L. Zhou (China), W.J. Deng, R. Hu, W. Yang, Y. Wang, G.C. Li, Z. Zhang > Contemporary esophageal cancer management by chemo radiation: survey of French radiation oncologists E. Blais (France), A. Huertas, M. Ozsahin, G. Créhange, F. Huguet, J. Bourhis, P. Maingon, M. Antoine, I. Troussier > Automated VMAT planning for postoperative treatment of advanced gastric cancer A.W. Sharfo (The Netherlands), F. Stieler, O. Kupfer, B.J.M. Heijmen, M.L.P. Dirkx, S. Breedveld, F. Wenz, F. Lohr, J. Boda-Heggemann, D. Buergy  PO-0785  PO-0782  PO-0783  PO-0784

> Outcomes from hypofractionated radiotherapy comparable to chemoradiotherapy in oesophageal cancer C. Jones (United Kingdom), K. Spencer, C. Hitchen, T. Pelly, B. Wood, P. Hatfield, A. Crellin, D. Sebag-Montefiore, R. Goody, T. Crosby, G. Radhakrishna > Neoadjuvant IMRT in pancreatic adenocarcinoma: benefit of dose escalation A. Rodriguez (Spain), C. Rubio, O. Hernando, M. Lopez, D. Zucca, M. De la Casa > MR imaging biomarkers for prediction of response to neoadjuvant treatment in oesophageal cancer

 PO-0786

 PO-0787

K. Owczarczyk (United Kingdom), C. Kelly-Morland, C. Yip, R. Neji, S. McElroy, M. Siddique, S. Ngan, A. Qureshi, J. Gossage, G. Cook, V. Goh

 PO-0788

POSTER Clinical track: Lower GI (colon, rectum, anus)

> Contact X Ray (CXB) boost for planned organ preservation in T2 T3 rectal cancer. French Experience J.P. Gérard (France), N. Barbet, C. Dejean, K. Benezery, R. Coquard, Y. Chateau, J. Gal, J. Doyen

 PO-0789

Programme and Exhibition Guide | POSTERS AND ELECTRONIC POSTERS

201